{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:24:46Z","timestamp":1787117086028,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>While traditional circulating biomarkers have demonstrated prognostic value in general lung cancer patients, their short-term predictive value in critical care settings remains unclear. This study aims to systematically evaluate the association between elevated multiple circulating biomarkers and short-term mortality in critically ill lung cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study searched databases including PubMed, Embase, Web of Science, Cochrane Library, and CNKI from inception to February 2026. Literatures that enrolled patients with severe lung cancer, reported data on the association between biomarkers and short-term mortality, and provided relative risks (RR) or convertible data were included. Meta-analysis was conducted using R software with the Hartung-Knapp-Sidik-Jonkman (HKSJ) method for random effects models and robust variance estimation (RVE) to handle correlated effect sizes from the same study. Heterogeneity was assessed, and subgroup analyses, meta-regression, and sensitivity analyses were performed to evaluate pooled effect sizes and publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 9 literatures, extracting 19 studies covering 4,436 critically ill lung cancer patients. The primary meta-analysis using RVE showed that elevated biomarkers were significantly associated with short-term mortality (pooled RR\u00a0=\u00a01.62, 95% CI: 1.09-2.41, P\u00a0=\u00a00.022). Among these, 17 studies showed positive associations, with pooled RR\u00a0=\u00a01.93 (95% CI: 1.50-2.48, P &amp;lt; 0.001). Subgroup analysis revealed significant differences in effect sizes across different outcomes, biomarker types, and geographical regions (all P &amp;lt; 0.01 between subgroups), with the inflammatory biomarker subgroup showing the highest effect size (RR\u00a0=\u00a02.44). Subgroup analysis by critical illness definition showed that the effect was significant in both ICU-admitted patients (RR\u00a0=\u00a01.38, 95% CI: 1.07-1.78) and patients with advanced\/terminal disease (RR\u00a0=\u00a02.45, 95% CI: 1.66-3.62). Meta-regression analysis indicated that outcome measures (90-day mortality) and patient region (North America) were significant factors influencing heterogeneity. Sensitivity analysis confirmed the robustness of results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Multi-biomarker detection provides important reference for risk stratification and treatment decision-making in critically ill lung cancer patients. Future clinical practice could combine traditional critical care scoring systems to establish individualized prognostic prediction models based on multiple biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1861784","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:35:27Z","timestamp":1787114127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between elevated multiple circulating biomarkers and short-term mortality in critically ill lung cancer patients: a meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Congcong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8850666251339451","DOI":"10.1177\/08850666251339451","article-title":"Prognosis of patients with lung cancer admitted to the intensive care unit: a systematic review and meta-analysis","author":"Elkhapery","year":"2025","journal-title":"J Intensive Care Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12885-025-13822-9","article-title":"The prognostic\/ predictive value of the systematic inflammatory response in patients receiving immunotherapy for non-small cell lung cancer: a systematic review and meta-analysis","volume":"25","author":"Saeed","year":"2025","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2023.11.003","article-title":"Predictive value of the APACHEII and SOFA scales in the mortality of cancer patients in intensive care","volume":"161","author":"Cuenca Fito","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2025-900","article-title":"Circulating tumor DNA as prognostic markers of non-small cell lung cancer (NSCLC): a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/cells13211785","article-title":"Prognostic indicators for precision treatment of non-small cell lung carcinoma","volume":"13","author":"Ghosh","year":"2024","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03318-3","article-title":"Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data","volume":"146","author":"Lathwal","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12885-025-14013-2","article-title":"Association between the lactate dehydrogenase-to-albumin ratio and 28-day mortality in septic patients with Malignancies: analysis of the MIMIC-IV database","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2025.2537619","article-title":"Deciphering the potential of the lactate dehydrogenase-to-albumin ratio as a prognostic biomarker in Malignancy: a systematic review and meta-analysis","volume":"137","author":"Dwi Purwati","year":"2025","journal-title":"Postgrad Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.571169","article-title":"Prognostic prediction models based on clinicopathological indices in patients with resectable lung cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s13019-024-03311-8","article-title":"Prognostic value of albumin-bilirubin grade in lung cancer: a meta-analysis","volume":"19","author":"Jiang","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2019.37.15_suppl.e14535","article-title":"Inflammatory biomarkers as pronostic factors of mortality in critical ILL oncology patients at ICU","volume":"37","author":"Macha","year":"2019","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1038\/s41598-026-36028-w","article-title":"Lactate to albumin ratio predicts one year mortality in ICU patients receiving invasive mechanical ventilation","volume":"16","author":"Mu","year":"2026","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"T143","DOI":"10.1016\/j.farma.2024.11.007","article-title":"Translated article] Relationship between lactate dehydrogenase and survival in patients with non-small-cell lung cancer receiving immunotherapy","volume":"49","author":"Rosique-Aznar","year":"2025","journal-title":"Farm Hosp"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.31222\/osf.io\/v7gm2_v1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/atm.atm_287_23","article-title":"Characteristics, management, and outcomes of patients with lung cancer admitted to a tertiary care intensive care unit over more than 20 years","volume":"19","author":"Al-Dorzi","year":"2024","journal-title":"Ann Thorac Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2024-1998","article-title":"Factors linked to lung cancer in MIMIC-IV database","volume":"17","author":"Fang","year":"2025","journal-title":"J Thorac Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.62347\/rnyp8960","article-title":"Development and validation of a nomogram for predicting 90-day mortality in patients with advanced lung cancer based on inflammatory and nutritional biomarkers","volume":"15","author":"Wang","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B20","article-title":"Analysis of factors influencing the prognosis of lung cancer patients in intensive care unit and construction of prediction model","volume":"23","author":"Long","year":"2025","journal-title":"Cancer Progression"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2022e12140","article-title":"Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19","volume":"55","author":"Peixoto","year":"2022","journal-title":"Braz J Med Biol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-4695.2019.11.008","article-title":"The value of serum PDCD5 and PCNA expression in evaluating the short-term prognosis of patients with lung cancer","volume":"18","author":"Zhao","year":"2019","journal-title":"J Clin Exp Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12879-025-12484-z","article-title":"Prediction hospital mortality for critical illness lung cancer patients with pneumonia","volume":"26","author":"Xu","year":"2026","journal-title":"BMC Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1038\/s41598-026-35005-7","article-title":"The red cell distribution width to albumin ratio as a novel predictor of 180-day mortality in lung cancer patients","volume":"16","author":"Zhang","year":"2026","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02105-5","article-title":"Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory Malignancy","volume":"27","author":"Tanaka","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2244","article-title":"Prognosis of lung cancer patients with life-threatening complications","volume":"131","author":"Soares","year":"2007","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1513\/annalsats.202506-672oc","article-title":"Oncologic and physiologic predictors of mortality after intensive care unit admission in patients with lung cancer","volume":"23","author":"Koch","year":"2026","journal-title":"Ann Am Thorac Soc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26102","DOI":"10.1038\/s41598-024-76052-2","article-title":"Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis","volume":"14","author":"Tong","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v11.i6.364","article-title":"Scoring systems in critically ill: which one to use in cancer patients","volume":"11","author":"Beniwal","year":"2022","journal-title":"World J Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v33i2.10","article-title":"Prognostic importance of lactate and blood gas parameters in predicting mortality in patients with critical Malignancies","volume":"33","author":"Erdur","year":"2023","journal-title":"Ethiop J Health Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/crj.70042","article-title":"Liver function biomarkers and lung cancer risk: a prospective cohort study in the UK Biobank","volume":"18","author":"Sun","year":"2024","journal-title":"Clin Respir J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.734735","article-title":"Hypoalbuminaemia as a prognostic biomarker of first-line treatment resistance in metastatic non-small cell lung cancer","volume":"8","author":"Stares","year":"2021","journal-title":"Front Nutr"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:35:39Z","timestamp":1787114139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1861784"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1861784","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1861784"}}